Recon: Makary says FDA won't reorganize product centers; Merck to spend $1B on US factory to produce Keytruda
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States